Foundation Medicine, Inc. Announces 2014 First Quarter Results And Recent Highlights

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Foundation Medicine, Inc. (NASDAQ: FMI) today reported total revenue of $11.5 million in the first quarter of 2014, compared to $9.7 million in the fourth quarter of 2013 and $5.2 million in the first quarter of 2013. Revenue from clinical testing in the first quarter was $7.1 million, which represents 34% growth in clinical revenue compared to the prior quarter. The company reported 4,702 clinical tests in the first quarter, up from 3,752 in the fourth quarter of 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news